浙江三美化工股份有限公司 关联交易管理制度 第一条 为规范浙江三美化工股份有限公司（以下简称"公司"）关联交易 行为，提高公司规范运作水平，保护公司和全体股东的合法权益，根据《中华人民 共和国公司法》《中华人民共和国证券法》《企业会计准则第 36 号——关联方披 露》《上市公司信息披露管理办法》等法律法规、部门规章、规范性文件，以及《上 海证券交易所股票上市规则》（以下简称"《股票上市规则》"）、《上海证券交 易所上市公司自律监管指引第 5 号——交易与关联交易》等业务规则和《浙江三美 化工股份有限公司章程》（以下简称《"公司章程》"）的有关规定，制定本制度。 第二条 公司关联交易行为应当合法合规，不得隐瞒关联关系，不得通过将 关联交易非关联化规避相关审议程序和信息披露义务。相关交易不得存在导致或者 可能导致公司出现被控股股东、实际控制人及其他关联人非经营性资金占用、为关 联人违规提供担保或者其他被关联人侵占利益的情形。 第三条 公司在审议关联交易事项时，应当详细了解交易标的的真实状况和 交易对方诚信记录、资信状况、履约能力等，审核评估相关交易的必要性、合理性 和对公司的影响，根据充分的定价依据确定交易价格。 ...

浙江三美化工股份有限公司 对外投资管理制度 （2025 年 4 月） 第一章 总 则 第三条 本制度所称"对外投资"是指公司为获取未来收益而将一定数量 的货币资金、股权以及经评估后的实物或无形资产作价出资，对外进行的各种形 式的投资活动，包括投资新建子公司、向子公司追加投资、与其他单位进行联营、 合营、兼并或进行股权收购、转让、项目资本增减等。 本制度所称"对外投资"不包括关联交易、对外担保、委托理财、外汇套期保 值及募集资金投资，涉及前述事项应分别适用《浙江三美化工股份有限公司关联 交易管理制度》《浙江三美化工股份有限公司对外担保管理制度》《浙江三美化 工股份有限公司委托理财管理制度》《浙江三美化工股份有限公司外汇衍生品交 易业务管理制度》及《浙江三美化工股份有限公司募集资金管理制度》的规定。 第四条 按照投资期限的长短，公司对外投资分为短期投资和长期投资。 短期投资主要指公司购入的能随时变现且持有时间不超过一年（含一年）的 投资，包括各种股票、债券、基金、分红型保险等以及上海证券交易所认定的其 他投资行为； 1 长期投资主要指投资期限超过一年，不能随时变现或不准备变现的各种投资， 包括债券投资、股权投资和 ...

浙江三美化工股份有限公司 2024 年度独立董事述职报告 本人作为浙江三美化工股份有限公司（以下简称"三美股份"或"公司"） 的独立董事，在2024年度工作中，根据《公司法》《证券法》《上市公司治理准则》 《上市公司独立董事管理办法》等相关法律法规及《公司章程》《独立董事工作 制度》等公司制度的规定，恪尽职守、勤勉尽责，积极履行独立董事的职责，积 极出席公司相关会议，促进公司规范运作，维护公司和全体股东的利益。现将2024 年度履职情况报告如下： 一、独立董事的基本情况 张陶勇：男，1971 年 1 月出生，中国国籍，无境外永久居留权，硕士研究 生学历，浙江工商大学会计学专业教授、硕士生导师，中国注册会计师非执业会 员。2017 年 12 月至今，在浙江工商大学任教授；2018 年 9 月至 2024 年 4 月， 任思美传媒股份有限公司独立董事；2020 年 4 月至今，任浙富控股集团股份有 限公司独立董事；2022 年 3 月至今，任汉嘉设计集团股份有限公司独立董事； 2022 年 5 月至今任三美股份独立董事。 作为公司独立董事，经自查，本人符合《上市公司独立董事管理办法》《上 海证券交易所上市公司自律 ...

Financial Performance - The company's operating revenue for 2024 reached ¥4,039,536,038.94, representing a year-on-year increase of 21.17% compared to ¥3,333,788,239.24 in 2023[23]. - Net profit attributable to shareholders for 2024 was ¥778,536,624.05, a significant increase of 178.40% from ¥279,644,841.86 in 2023[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥748,496,190.93, reflecting a year-on-year growth of 257.74%[23]. - The net cash flow from operating activities increased by 46.52% to ¥708,863,907.93, primarily due to an increase in cash received from sales of goods and services[26]. - The company's net assets attributable to shareholders rose by 9.31% to ¥6,441,177,295.74 at the end of 2024, compared to ¥5,892,485,705.60 at the end of 2023[24]. - Total assets increased by 6.11% to ¥7,140,168,177.79 at the end of 2024, up from ¥6,728,954,607.88 in 2023[24]. - Basic earnings per share for 2024 were ¥1.28, a 178.26% increase from ¥0.46 in 2023[25]. - The weighted average return on equity for 2024 was 12.61%, an increase of 7.78 percentage points from 4.83% in 2023[25]. Dividend Distribution - The company plans to distribute a cash dividend of 4.50 yuan per 10 shares (including tax) to all shareholders, totaling approximately 273,040,171.65 yuan (including tax) based on 606,755,937 shares available for distribution[4]. - The company has not proposed any stock dividends or capital reserve transfers to increase share capital in the profit distribution plan[4]. - The cash dividend represents 35.07% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which was RMB 778,536,624.05[186]. - Over the last three accounting years, the cumulative cash dividend paid was RMB 559,351,344.11, exceeding the average annual net profit of RMB 514,584,887.32, resulting in a cash dividend ratio of 108.70%[187]. - The company’s profit distribution policy emphasizes a minimum cash dividend of 20% of the audited net profit if conditions are met, with higher percentages for mature companies without major capital expenditures[181]. Risk Management - The company has disclosed potential risks in the report, including specific risks and countermeasures in the section on future development[7]. - The report includes forward-looking statements that may differ significantly from actual future results due to various factors[5]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[6]. - The company has not violated decision-making procedures for providing guarantees[6]. - The company has no instances of more than half of the directors being unable to guarantee the authenticity of the annual report[6]. Production and Capacity - The production of refrigerants reached 162,574.97 tons in 2024, a 3.86% increase compared to 2023[39]. - The company is actively expanding its production capacity, with projects like the 6,000 tons/year lithium hexafluorophosphate project in Fujian now in trial production[35]. - The company has a production capacity of 65,000 tons for HFC-134a, with a 2024 production quota of 51,500 tons, accounting for 23.88% of the national production quota[53]. - The production capacity for HCFC-141b is 35,600 tons, with a production quota of 14,500 tons for 2024, representing 68.92% of the national quota[55]. - The company holds a capacity of 22,100 tons for anhydrous hydrofluoric acid (AHF), which is essential for the production of fluorinated refrigerants and foaming agents[58]. Environmental and Safety Measures - The company is focusing on safety and environmental management, conducting regular inspections and training for employees[36]. - The company has established environmental protection mechanisms and is classified as a key pollutant discharge unit[193]. - The total emissions of nitrogen oxides from the boiler and various workshops amounted to 8.5268 tons, with a concentration of 3.33 mg/m3, well below the standard of 50 mg/m3[194]. - The total emissions of sulfur dioxide were recorded at 1.287 tons, with a concentration of 4.75 mg/m3, also below the standard of 35 mg/m3[194]. - The company has implemented comprehensive pollution control measures, ensuring that all wastewater treatment facilities and online monitoring systems are functioning normally[200]. Research and Development - Research and development expenses increased by 52.57% to CNY 80,948,868.53 due to the expansion of R&D projects[67]. - The company invested in 32 R&D projects, focusing on optimizing production processes and developing new products, including environmentally friendly refrigerants and fine chemicals[108]. - The company holds 123 authorized patents, including 59 invention patents, with a focus on its main products such as AHF, HFC-125, and HFC-134a[108]. - The proportion of R&D personnel to total employees is 13.70%, with a total of 279 R&D staff[80]. Governance and Compliance - The board of directors has ensured the authenticity, accuracy, and completeness of the annual report[3]. - The company has established a remuneration committee to provide recommendations based on industry and regional standards[164]. - The company has not reported any significant deficiencies in internal control during the reporting period[192]. - The company has maintained stable leadership with no changes in key management personnel during the reporting period[161]. - The company has not reported any penalties from securities regulatory agencies in the past three years[165]. Market and Competitive Landscape - The company is focusing on enhancing market positioning and customer relationship management to increase market share and brand influence[142]. - The company faces significant export risks due to rising global trade protectionism, with investigations into HFCs refrigerants by the US, India, and Argentina impacting export operations[150]. - The company is monitoring foreign exchange risks and plans to use forward foreign exchange contracts or currency swaps to mitigate potential impacts on export business[150]. - The fluorochemical industry is cyclical, with significant fluctuations influenced by macroeconomic factors and downstream demand, impacting product prices[146]. Employee Engagement and Compensation - The company has implemented a performance-based salary system for employees, with adjustments based on monthly and annual performance[191]. - The total compensation for the company's executives during the reporting period amounted to 6.9421 million CNY[158]. - The company has a total of 2,036 employees, with 988 in the parent company and 1,048 in major subsidiaries[176]. - The company emphasizes performance-oriented compensation, which includes base salary, performance pay, bonuses, and various allowances[178].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,211,884,685.98, representing a year-on-year increase of 26.42% compared to CNY 958,608,904.06 in the same period last year[4]. - Net profit attributable to shareholders was CNY 400,520,885.73, a significant increase of 159.59% from CNY 154,292,124.48 in the previous year[4]. - The net cash flow from operating activities reached CNY 366,078,368.16, up 166.96% from CNY 137,126,386.76 in the same period last year[4]. - Basic and diluted earnings per share were both CNY 0.66, reflecting a 164.00% increase from CNY 0.25 in the previous year[4]. - Operating profit for Q1 2025 was CNY 503,566,265.11, compared to CNY 184,396,471.67 in the same period last year, indicating an increase of about 172.5%[16]. - The total comprehensive income for Q1 2025 was CNY 397,942,240.53, compared to CNY 154,284,732.56 in Q1 2024, indicating an increase of about 158.5%[17]. Revenue and Costs - Total operating revenue for Q1 2025 reached RMB 1,211,884,685.98, an increase of 26.3% compared to RMB 958,608,904.06 in Q1 2024[15]. - Total operating costs decreased to RMB 720,128,651.53 in Q1 2025 from RMB 774,751,740.22 in Q1 2024, reflecting a reduction of 7.0%[15]. - Operating costs specifically dropped from RMB 740,324,508.14 in Q1 2024 to RMB 645,975,322.45 in Q1 2025, a decrease of 12.7%[15]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,925,086,191.92, a 10.99% increase from CNY 7,140,168,177.79 at the end of the previous year[5]. - Current assets increased to RMB 4,646,764,757.12 as of March 31, 2025, up from RMB 4,101,734,611.75 at the end of 2024, representing a growth of 13.3%[11]. - Total liabilities increased to RMB 938,593,235.77 as of March 31, 2025, up from RMB 576,392,419.50 at the end of 2024, indicating a rise of 62.8%[13]. - Shareholders' equity attributable to shareholders was CNY 6,866,473,127.55, up 6.60% from CNY 6,441,177,295.74 at the end of the previous year[5]. - Shareholders' equity totaled RMB 6,986,492,956.15 as of March 31, 2025, compared to RMB 6,563,775,758.29 at the end of 2024, reflecting an increase of 6.5%[13]. Shareholder Information - The company reported a total of 14,351 common shareholders at the end of the reporting period[7]. - The top three shareholders held a combined 62.84% of the shares, with the largest shareholder owning 37.83%[8]. Cash Flow and Investments - The cash flow from operating activities for Q1 2025 was CNY 366,078,368.16, compared to CNY 137,126,386.76 in Q1 2024, marking an increase of about 167.5%[20]. - The cash and cash equivalents increased by CNY 266,957,718.04 in Q1 2025, compared to an increase of CNY 13,460,502.87 in Q1 2024[20]. - The investment activities generated a net cash outflow of CNY -241,025,866.30 in Q1 2025, compared to CNY -127,755,704.79 in Q1 2024, indicating increased investment activities[20]. Research and Development - Research and development expenses for Q1 2025 amounted to CNY 20,847,227.57, up from CNY 15,440,059.75 in Q1 2024, which is an increase of approximately 35.5%[16]. Other Information - The increase in revenue and profit was primarily driven by rising sales prices[6]. - The company has not reported any significant new strategies or product developments during the conference call[10]. - The company incurred financial expenses of CNY -18,874,903.19 in Q1 2025, a decrease from CNY -31,304,134.65 in Q1 2024, showing an improvement in financial management[16]. - The company reported a significant increase in accounts receivable, which rose to RMB 468,273,954.67 from RMB 302,554,869.23, a growth of 54.7%[11]. - Inventory levels increased to RMB 616,816,338.28 as of March 31, 2025, compared to RMB 561,176,679.01 at the end of 2024, representing a rise of 9.9%[11].

证券代码：603379 证券简称：三美股份 公告编号：2025-031 浙江三美化工股份有限公司 关于董事会换届选举的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江三美化工股份有限公司（以下简称"公司"或"三美股份"）第六届董 事会任期即将届满，根据《公司法》《证券法》《上海证券交易所股票上市规则》 等法律法规、规范性文件及《公司章程》的有关规定，公司于 2025 年 4 月 26 日召开第六届董事会第十九次会议，审议通过了《关于换届选举第七届董事会非 独立董事的议案》《关于换届选举第七届董事会独立董事的议案》。现将相关情 况公告如下： 一、董事会换届选举情况 （一）非独立董事候选人提名情况 经董事会提名委员会对第七届董事会非独立董事候选人的任职资格审查，公 司董事会决议提名胡淇翔、徐志雄、徐能武、王富强、潘航为公司第七届董事会 非独立董事候选人。上述非独立董事候选人简历详见附件。 （二）独立董事候选人提名情况 经董事会提名委员会对第七届董事会独立董事候选人的任职资格审查，公司 董事会决议提名张陶勇、夏祖兴、 ...

（二）项目建设情况 近年来，公司在原有氟化工产业基础上，积极完善上下游产业链一体化布局。 报告期内，公司稳步推进各项目建设，主要项目情况如下： 福建东莹年产 6000 吨六氟磷酸锂及年产 100 吨五氟化磷项目，已建成六氟 磷酸锂产能为 1500 吨/年(其中，六氟磷酸锂晶体产能为 1000 吨/年，六氟磷酸锂 溶液产能为 500 吨(折固)/年)，前述产能已于 2024 年 10 月中旬进行了试生产。 浙江三美 5000 吨/年聚全氟乙丙烯及 5000 吨/年聚偏氟乙烯项目，已基本完成主 体建筑，进入设备安装阶段。 森田新材料 AHF 二期扩产项目、BOE 产能扩建项目，已完成设备安装。盛 美锂电年产 3000 吨（折固）双氟磺酰亚胺锂项目，已基本完成相关技改工作。 浙江三美化工股份有限公司 2024 年度董事会工作报告 一、2024 年度公司经营情况讨论与分析 （一）主营业务情况 2024 年，国家对第二、三代氟制冷剂均实行生产配额管理，行业的供需格 局、竞争格局进一步优化，公司制冷剂产品均价同比涨幅较大，盈利能力大幅提 升。 报告期内，公司实现营业收入 4,039,536,038.94 元，同比增长 2 ...

二、本人任职资格符合下列法律、行政法规和部门规章以及公司规章的要求： （一）《中华人民共和国公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定； （三）中国证监会《上市公司独立董事管理办法》、上海证券交易所自律监管规则 以及公司章程有关独立董事任职资格和条件的相关规定； （四）中共中央纪委、中共中央组织部《关于规范中管干部辞去公职或者退（离） 休后担任上市公司、基金管理公司独立董事、独立监事的通知》的规定； （五）中共中央组织部《关于进一步规范党政领导干部在企业兼职（任职）问题的 意见》的相关规定； 独立董事候选人声明与承诺 本人已经参加培训并取得证券交易所认可的相关培训证明材料。 本人张陶勇，已充分了解并同意由提名人浙江三美化工股份有限公司董事会提名为 浙江三美化工股份有限公司第七届董事会独立董事候选人。本人公开声明，本人具备独 立董事任职资格，保证不存在任何影响本人担任浙江三美化工股份有限公司独立董事独 立性的关系，具体声明并承诺如下： 一、本人具备上市公司运作的基本知识，熟悉相关法律、行政法规、部门规章及其 他规范性文件，具有 5 年以上法律、经济、会计、财务、管 ...

浙江三美化工股份有限公司董事会审计委员会 2024 年度对会计师事务所履行监督职责的情况报告 浙江三美化工股份有限公司（以下简称"公司"）聘请立信会计师事务所（特 殊普通合伙）（以下简称"立信"）为公司 2024 年度财务和内部控制审计机构。 根据财政部、国务院国有资产监督管理委员会、中国证券监督管理委员会颁布的 《国有企业、上市公司选聘会计师事务所管理办法》，公司董事会审计委员会切 实对立信在 2024 年度的审计工作情况履行了监督职责，具体情况汇报如下： 一、 2024 年年审会计师事务所基本情况 1、会计师事务所基本情况 立信会计师事务所（特殊普通合伙）（以下简称"立信"）由我国会计泰斗 潘序伦博士于 1927 年在上海创建，1986 年复办，2010 年成为全国首家完成改制 的特殊普通合伙制会计师事务所，注册地址为上海市，首席合伙人为朱建弟先生。 立信是国际会计网络 BDO 的成员所，长期从事证券服务业务，新证券法实施前具 有证券、期货业务许可证，具有 H 股审计资格，并已向美国公众公司会计监督委 员会（PCAOB）注册登记。 截至 2024 年末，立信拥有合伙人 296 名、注册会计师 2,498 ...

浙江三美化工股份有限公司 股东回报规划（2025—2027年） 为进一步推动浙江三美化工股份有限公司（以下简称"公司"）建立科学、 持续、稳定的分红机制，积极回报股东，引导投资者形成稳定的投资回报预期， 保护投资者的合法权益，根据《中华人民共和国公司法》《关于进一步落实上市 公司现金分红有关事项的通知》《上市公司监管指引第 3 号——上市公司现金分 红》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关法律、 法规、规范性文件以及《浙江三美化工股份有限公司章程》（以下简称"《公司 章程》"）等公司治理制度的规定，特制定《浙江三美化工股份有限公司股东回 报规划（2025-2027 年）》（以下简称"本规划"）。具体内容如下： 一、本规划的制定原则 本规划的制定着眼于对投资者的合理投资回报、公司的长远和可持续发展， 综合分析考虑公司战略发展规划、行业发展趋势、公司实际经营情况及股东的要 求和意愿，以求为投资者建立合理、科学、有效的回馈机制，从而保证公司实行 积极、持续、稳定的利润分配政策。 二、2025—2027年股东回报规划 (一) 利润分配形式 公司采用现金、股票或者现金与股票相结合的方式分配 ...